← FDA DRUG APPROVALS

FDA ANDA · ANDA085738

BETAMETHASONE SODIUM PHOSPHATE

Sponsor: WATSON LABS

APPLICATION
ANDA085738
TYPE
ANDA
ORIGINAL APPROVAL
1979-01-30
LATEST ACTION
1999-02-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BETAMETHASONE SODIUM PHOSPHATEDiscontinued
BETAMETHASONE SODIUM PHOSPHATE EQ 3MG BASE/ML · INJECTABLE · INJECTION

Approval history

1999-02-19Manufacturing (CMC) · Supplement 23AP
1999-02-02Manufacturing (CMC) · Supplement 22AP
1996-12-04Manufacturing (CMC) · Supplement 20AP
1996-04-30Labeling · Supplement 19AP
1995-05-17Manufacturing (CMC) · Supplement 18AP
1992-08-18Manufacturing (CMC) · Supplement 15AP
1992-08-18Manufacturing (CMC) · Supplement 16AP
1988-10-21Manufacturing (CMC) · Supplement 13AP
1988-10-21Manufacturing (CMC) · Supplement 11AP
1988-10-21Manufacturing (CMC) · Supplement 12AP
1986-08-19Manufacturing (CMC) · Supplement 7AP
1982-09-13Manufacturing (CMC) · Supplement 5AP
1982-03-22Manufacturing (CMC) · Supplement 4AP
1979-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →